Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic

Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic Publisher Pubmed

Bikson M¹ ; Hanlon CA² ; Woods AJ³ ; Gillick BT⁴ ; Charvet L⁵ ; Lamm C⁶ ; Madeo G⁷ ; Holczer A⁸ ; Almeida J^{9, 10} ; Antal A^{11, 12} ; Ay MR¹³ ; Baeken C^{14, 15, 16} ; Blumberger DM^{17, 18} ; Campanella S¹⁹ Show All Authors

Bikson M¹
Hanlon CA²
Woods AJ³
Gillick BT⁴
Charvet L⁵
Lamm C⁶
Madeo G⁷
Holczer A⁸
Almeida J^{9, 10}
Antal A^{11, 12}
Ay MR¹³
Baeken C^{14, 15, 16}
Blumberger DM^{17, 18}
Campanella S¹⁹
Camprodon JA²⁰
Christiansen L²¹
Loo C²²
Crinion JT²³
Fitzgerald P²⁴
Gallimberti L⁷
Ghobadiazbari P^{25, 26}
Ghodratitoostani I²⁷
Grabner RH²⁸
Hartwigsen G²⁹
Hirata A³⁰
Kirton A³¹
Knotkova H^{32, 33}
Krupitsky E³⁴
Marangolo P^{35, 36}
Nakamurapalacios EM³⁷
Potok W³⁸
Praharaj SK³⁹
Ruff CC⁴⁰
Schlaug G⁴¹
Siebner HR^{21, 42}
Stagg CJ⁴³
Thielscher A^{21, 44}
Wenderoth N³⁸
Yuan TF⁴⁵
Zhang X⁴⁶
Ekhtiari H⁴⁷

Show Affiliations

1. Department of Biomedical Engineering, The City College of New York of CUNY, New York, NY, United States
2. Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States
3. Center for Cognitive Aging and Memory, McKnight Brain Institute, Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, United States
4. Department of Rehabilitation Medicine, School of Medicine, University of Minnesota, Minneapolis, MN, United States
5. Department of Neurology, NYU Grossman School of Medicine, New York, NY, United States
6. Social, Cognitive and Affective Neuroscience Unit, Department of Cognition, Emotion, and Methods in Psychology, Faculty of Psychology, University of Vienna, Vienna, Austria
7. Novella Fronda Foundation, Padua, Italy
8. Department of Neurology, Albert Szent-Gyorgyi Health Center, Faculty of Medicine, University of Szeged, Hungary
9. Proaction Lab, Faculty of Psychology and Educational Sciences, University of Coimbra, Portugal
10. CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra, Portugal
11. Department of Clinical Neurophysiology, University Medical Center Gottingen, Gottingen, Germany
12. Institute of Medical Psychology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
13. Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences, Tehran, Iran
14. Faculty of Medicine and Health Sciences, Ghent Experimental Psychiatry (GHEP) Lab, Ghent University, Ghent, Belgium
15. Department of Psychiatry, University Hospital (UZBrussel), Brussels, Belgium
16. Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands
17. Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Canada
18. Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada
19. Laboratoire de Psychologie Medicale et D'Addiction, ULB Neuroscience Institute (UNI), Universite Libre de Bruxelles (ULB), Place Vangehuchten, Brussels, B-1020, Belgium
20. Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
21. Danish Research Centre for Magnetic Resonance (DRCMR), Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
22. School of Psychiatry & Black Dog Institute, University of New South Wales, Sydney, Australia
23. Institute of Cognitive Neuroscience, University College London, London, United Kingdom
24. Epworth Centre for Innovation in Mental Health, Epworth HealthCare and Department of Psychiatry, Monash University, Camberwell, Victoria, Australia
25. Department of Biomedical Engineering, Shahed University, Tehran, Iran
26. Iranian National Center for Addiction Studies (INCAS), Tehran, Iran
27. Neurocognitive Engineering Laboratory (NEL), Center for Mathematical Sciences Applied to Industry, Institute of Mathematical and Computer Sciences, University of Sao Paulo, Brazil
28. Educational Neuroscience, Institute of Psychology, University of Graz, Austria
29. Lise Meitner Research Group Cognition and Plasticity, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
30. Department of Electrical and Mechanical Engineering, Nagoya Institute of Technology, Nagoya, Japan
31. Departments of Pediatrics and Clinical Neuroscience, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
32. MJHS Institute for Innovation in Palliative Care, New York, NY, United States
33. Department of Family and Social Medicine, Albert Einstein College of Medicine, The Bronx, NY, United States
34. First Pavlov State Medical University, V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology, St. Petersburg, Russian Federation
35. Department of Humanities Studies, University Federico II, Naples, Italy
36. Aphasia Research Lab, IRCCS Santa Lucia Foundation, Rome, Italy
37. Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil
38. Neural Control of Movement Lab, Department of Health Science and Technology, ETH Zurich, Switzerland
39. Department of Psychiatry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
40. Zurich Center for Neuroeconomics (ZNE), Department of Economics, University of Zurich, Zurich, Switzerland
41. Neuroimaging-Neuromodulation and Stroke Recovery Laboratory, Department of Neurology, Beth Israel Deaconess Medical Center and Baystate Medical Center, UMass Medical School, MA, United States
42. Institute of Clinical Medicine, Faculty of Health Sciences and Medicine, University of Copenhagen, Copenhagen, Denmark
43. Wellcome Centre for Integrative Neuroimaging and MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
44. Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
45. Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
46. CAS Key Laboratory of Brain Function and Disease and School of Life Sciences, Division of Life Science and Medicine, University of Science & Technology of China, Hefei, China
47. Laureate Institute for Brain Research, Tulsa, OK, United States

Source: Brain Stimulation Published:2020

Abstract

Background: The COVID-19 pandemic has broadly disrupted biomedical treatment and research including non-invasive brain stimulation (NIBS). Moreover, the rapid onset of societal disruption and evolving regulatory restrictions may not have allowed for systematic planning of how clinical and research work may continue throughout the pandemic or be restarted as restrictions are abated. The urgency to provide and develop NIBS as an intervention for diverse neurological and mental health indications, and as a catalyst of fundamental brain research, is not dampened by the parallel efforts to address the most life-threatening aspects of COVID-19; rather in many cases the need for NIBS is heightened including the potential to mitigate mental health consequences related to COVID-19. Objective: To facilitate the re-establishment of access to NIBS clinical services and research operations during the current COVID-19 pandemic and possible future outbreaks, we develop and discuss a framework for balancing the importance of NIBS operations with safety considerations, while addressing the needs of all stakeholders. We focus on Transcranial Magnetic Stimulation (TMS) and low intensity transcranial Electrical Stimulation (tES) - including transcranial Direct Current Stimulation (tDCS) and transcranial Alternating Current Stimulation (tACS). Methods: The present consensus paper provides guidelines and good practices for managing and reopening NIBS clinics and laboratories through the immediate and ongoing stages of COVID-19. The document reflects the analysis of experts with domain-relevant expertise spanning NIBS technology, clinical services, and basic and clinical research – with an international perspective. We outline regulatory aspects, human resources, NIBS optimization, as well as accommodations for specific demographics. Results: A model based on three phases (early COVID-19 impact, current practices, and future preparation) with an 11-step checklist (spanning removing or streamlining in-person protocols, incorporating telemedicine, and addressing COVID-19-associated adverse events) is proposed. Recommendations on implementing social distancing and sterilization of NIBS related equipment, specific considerations of COVID-19 positive populations including mental health comorbidities, as well as considerations regarding regulatory and human resource in the era of COVID-19 are outlined. We discuss COVID-19 considerations specifically for clinical (sub-)populations including pediatric, stroke, addiction, and the elderly. Numerous case-examples across the world are described. Conclusion: There is an evident, and in cases urgent, need to maintain NIBS operations through the COVID-19 pandemic, including anticipating future pandemic waves and addressing effects of COVID-19 on brain and mind. The proposed robust and structured strategy aims to address the current and anticipated future challenges while maintaining scientific rigor and managing risk. © 2020 The Authors

Related Docs

View other Related Docs

1. Digitalized Transcranial Electrical Stimulation: A Consensus Statement, Clinical Neurophysiology (2022)

2. Transcranial Electrical and Magnetic Stimulation (Tes and Tms) for Addiction Medicine: A Consensus Paper on the Present State of the Science and the Road Ahead, Neuroscience and Biobehavioral Reviews (2019)

3. A Systematic Review of Randomized Controlled Trials on Efficacy and Safety of Transcranial Direct Current Stimulation in Major Neurodevelopmental Disorders: Adhd, Autism, and Dyslexia, Brain and Behavior (2022)

4. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)

5. The Roles of Eph Receptors, Neuropilin-1, P2x7, and Cd147 in Covid-19-Associated Neurodegenerative Diseases: Inflammasome and Jak Inhibitors As Potential Promising Therapies, Cellular and Molecular Biology Letters (2022)

6. Pathophysiological Clues to How the Emergent Sars-Cov-2 Can Potentially Increase the Susceptibility to Neurodegeneration, Molecular Neurobiology (2021)

7. A Predictive Study Between Anxiety and Fear of Covid-19 With Psychological Behavior Response: The Mediation Role of Perceived Stress, Frontiers in Psychiatry (2022)

8. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (7)

Abbas Tafakhori (2)

Style	Citing Format
MLA	Bikson M, et al.. "Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic." Brain Stimulation, vol. 13, no. 4, 2020, pp. 1124-1149.
APA	Bikson M, Hanlon CA, Woods AJ, Gillick BT, Charvet L, Lamm C, Madeo G, Holczer A, Almeida J, Antal A, Ay MR, Baeken C, Blumberger DM, Campanella S, Camprodon JA, Christiansen L, Loo C, Crinion JT, Fitzgerald P, ... Ekhtiari H (2020). Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic. Brain Stimulation, 13(4), 1124-1149.
Chicago	Bikson M, Hanlon CA, Woods AJ, Gillick BT, Charvet L, Lamm C, Madeo G, et al.. "Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic." Brain Stimulation 13, no. 4 (2020): 1124-1149.
Harvard	Bikson M et al. (2020) 'Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic', Brain Stimulation, 13(4), pp. 1124-1149.
Vancouver	Bikson M, Hanlon CA, Woods AJ, Gillick BT, Charvet L, Lamm C, et al.. Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic. Brain Stimulation. 2020;13(4):1124-1149.
BibTex	@article{ author = {Bikson M and Hanlon CA and Woods AJ and Gillick BT and Charvet L and Lamm C and Madeo G and Holczer A and Almeida J and Antal A and Ay MR and Baeken C and Blumberger DM and Campanella S and Camprodon JA and Christiansen L and Loo C and Crinion JT and Fitzgerald P and Gallimberti L and Ghobadiazbari P and Ghodratitoostani I and Grabner RH and Hartwigsen G and Hirata A and Kirton A and Knotkova H and Krupitsky E and Marangolo P and Nakamurapalacios EM and Potok W and Praharaj SK and Ruff CC and Schlaug G and Siebner HR and Stagg CJ and Thielscher A and Wenderoth N and Yuan TF and Zhang X and Ekhtiari H}, title = {Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic}, journal = {Brain Stimulation}, volume = {13}, number = {4}, pages = {1124-1149}, year = {2020} }
RIS	TY - JOUR AU - Bikson M AU - Hanlon CA AU - Woods AJ AU - Gillick BT AU - Charvet L AU - Lamm C AU - Madeo G AU - Holczer A AU - Almeida J AU - Antal A AU - Ay MR AU - Baeken C AU - Blumberger DM AU - Campanella S AU - Camprodon JA AU - Christiansen L AU - Loo C AU - Crinion JT AU - Fitzgerald P AU - Gallimberti L AU - Ghobadiazbari P AU - Ghodratitoostani I AU - Grabner RH AU - Hartwigsen G AU - Hirata A AU - Kirton A AU - Knotkova H AU - Krupitsky E AU - Marangolo P AU - Nakamurapalacios EM AU - Potok W AU - Praharaj SK AU - Ruff CC AU - Schlaug G AU - Siebner HR AU - Stagg CJ AU - Thielscher A AU - Wenderoth N AU - Yuan TF AU - Zhang X AU - Ekhtiari H TI - Guidelines for Tms/Tes Clinical Services and Research Through the Covid-19 Pandemic JO - Brain Stimulation VL - 13 IS - 4 SP - 1124 EP - 1149 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract